Quick Takeaways
- TCG Crossover GP II, LLC filed SCHEDULE 13G for Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share (TECX).
- Disclosed ownership: 6.2%.
- Date of event: 12 Feb 2026.
Quoteable Key Fact
"TCG Crossover GP II, LLC disclosed 6.2% ownership in Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share (TECX) on 12 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 3.1% | 584,882 | 0 | 584,882 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund II, L.P. | 3.1% | 584,882 | 0 | 584,882 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover GP III, LLC | 3.1% | 584,878 | 0 | 584,878 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund III, L.P. | 3.1% | 584,878 | 0 | 584,878 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| Chen Yu | 6.2% | 1,169,760 | 0 | 1,169,760 | /s/ Craig Skaling | Craig Skaling, as Attorney-in-Fact for Chen Yu |